Evaluation of Platelet Function in Pregnancy With Multiple Electrode Aggregometry (MULPP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01881698|
Recruitment Status : Unknown
Verified October 2013 by Reinhard Hahn, Medical University of Vienna.
Recruitment status was: Recruiting
First Posted : June 20, 2013
Last Update Posted : October 11, 2013
|Condition or disease||Intervention/treatment|
|Platelet Function Pregnancy||Other: Platelet function during pregnancy Multiple Electrode Aggregometry (Multiplate@) device|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||200 participants|
|Target Follow-Up Duration:||7 Months|
|Official Title:||Multiple Electrode Aggregometry and Platelet Function in Pregnancy|
|Study Start Date :||October 2013|
|Estimated Primary Completion Date :||May 2015|
|Estimated Study Completion Date :||May 2015|
- Other: Platelet function during pregnancy Multiple Electrode Aggregometry (Multiplate@) device
Observation of platelet function in pregnancy
- Change of platelet function [ Time Frame: 4x, as specified below ]
Measurement of change of platelet function by the Multiplate® device. First measurement (baseline measurement) at enrollment into the trial. Second measurement during government-mandated gynaecological evaluation, around the 20th week of pregnancy.
Third measurement immediately prior to delivery. Last measurement one week after delivery. 2nd, 3rd and 4th measurement for assessment of change from baseline.
- Platelet-associated complications [ Time Frame: 4x, as specified below (baseline, 20th week) ]
Record of bleeding events, preeclampsia, HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.
Time points: at every assessment of primary outcome measure, as described above.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01881698
|Contact: Reinhard Hahn, MD||0043 1 40400 ext email@example.com|
|Contact: Albert M de Bettignies||0043 1 firstname.lastname@example.org|
|Universitätsklinik für Frauenheilkunde, Allgemeines Krankenhaus der Stadt Wien||Recruiting|
|Vienna, Austria, 1090|
|Principal Investigator:||Reinhard Hahn, MD||Department of Anaesthesia, General Intensive Care and Pain Management, Medical University Vienna|